Randomized trial of the efficacy of trial-based cognitive therapy for obsessive-compulsive disorder: preliminary findings
| Autor: | Eleonardo Pereira Rodrigues, Ana Jardel Batista Fechine, Antonio César Oliveira, Cristiane Francisca Ferreira Matos, Cristiane de Medeiros Passarela, Curt Hemanny, Francimeuda de Morais Dias, José Wilson Batista, Luciana de Carvalho Nogueira Albuquerque, Myrla Sirqueira Soares, Pedro Evangelista Coelho Neto, Vanessa Pires de Carvalho Araújo, Zila Mendes Ayres, Irismar Reis de Oliveira |
|---|---|
| Jazyk: | English<br />Spanish; Castilian<br />Portuguese |
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | Trends in Psychiatry and Psychotherapy, Vol 45 (2023) |
| Druh dokumentu: | article |
| ISSN: | 2238-0019 2237-6089 |
| DOI: | 10.47626/2237-6089-2021-0247 |
| Popis: | Abstract Introduction Obsessive-compulsive disorder (OCD) is the fourth most prevalent mental disorder and is a disabling condition. OCD is associated with anatomical and functional changes in the brain, in addition to dysfunctional cognitions. The treatments of choice are selective serotonin reuptake inhibitors, cognitive-behavioral therapy (CBT), and exposure and response prevention (ERP). Trial-based cognitive therapy (TBCT) is a recent and empirically validated psychotherapy with a focus on restructuring dysfunctional negative core beliefs (CBs). The objective of this study was to evaluate the efficacy of TBCT relative to ERP for treatment of OCD. Methods A randomized, single-blind clinical trial was conducted, randomizing 26 patients for individual treatment with TBCT (n = 12) or ERP (n = 14). The groups were evaluated at baseline, at the end of 3 months (12 sessions), and at 3, 6, and 12-month follow-ups. Results Both approaches reduced the severity of symptoms with large effect sizes. These results were maintained at the 12-month follow-up assessment. Conclusion TBCT may be a valid and promising treatment for this disorder. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|